Between 15 and 20 months of age, 36–62% of BCL6-overexpressing mice had developed B-cell lymphoma (compared to 2–8% in wild-type mice), and 75% of these cases resembled DLBCL. Here, BCL6 is linked to diffuse large B-cell lymphoma.